📰 Resistant Depression News
Resistant Depression News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resistant Depression. Real-time updates on events, politics, business and more.
January 15, 2024
Jennifer Coughlin, M.D., is co-founder and co-director of Johns Hopkins’ Brain Health Program and an associate professor of psychiatry and behavioral sciences. Ana Soule, C.R.N.P., is a psychiatric nurse practitioner at the Brain Health Program with dedicated expertise in the diagnosis and treatment of young adults with mood disorders. What is Treatment-Resistant Depression? While thereJennifer Coughlin, M.D., is co-founder and co-director of Johns Hopkins’ Brain Health Program and an associ...
November 22, 2022
We aim to provide consensus-based recommendations on the definition and management of treatment-resistant depression in adults in Southeast Asia region.
October 26, 2022
Compass shares lost 82% of their value over the past 12 months. Read what this may mean for a company bringing a form of therapy using psychedelic drug psilocybin to market. Read more here.
October 3, 2022
Depression is common—and on the rise—but may occur for different reasons. Here, doctors explain 10 common types of depression and how to tell the difference.
June 14, 2022
Antidepressant drugs have been the mainstay for treating patients with major depressive disorder. However, with a rapid rise in the rates of major depressive disorder, there has been a substantial increase in the resistance to antidepressants in the last decade. This has augmented the need for alternative treatment modalities, including repetitive transcranial magnetic stimulation. This review assesses the progress repetitive transcranial magnetic stimulation has made in treating patients resist...
June 7, 2022
Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy.
June 4, 2022
For severe depression, antidepressants are the first line of treatment. Psychotherapy is often used along with antidepressants. Now, findings from a large
May 18, 2022
/PRNewswire/ - Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) is pleased to announce that its CEO, Dr....
May 2, 2022
Even if your depression does not seem to be responding to drug treatment, there are many other options to reduce or eliminate symptoms. Learn more from WebMD about various therapies available for treatment-resistant depression.
March 30, 2022
- Highlights included positive Phase 2b data with COMP360 from a ground-breaking treatment resistant depression (TRD) trial, highly encouraging Phase 2a proof-of-mechanism data with RL-007 in cognitive